• Freedom
  • Innovation
  • Growth


Op/Ed RSS Feed
Publication Type 
August 5, 2020

Rather Than Pour Trillions into Infrastructure Funding, the Feds Should Get Out of the Way of Private Investment

If we really do want America’s critical infrastructure maintained, modernized and continually expanded, instead of borrowing and spending trillions of dollars on a small portion of our overall infrastructure, the most important thing government at all levels could do is just get out of the way.

August 4, 2020

New SEC Proxy Voting Rule Protects Everyday Investors

The Securities and Exchange Commission (SEC) adopted a new, long-overdue rule reining in abuses within the obscure but important world of proxy advisory services. 

August 2, 2020

4 Reasons Why Trump Can't Be Written Off--Yet

At this point, Trump has an uphill battle to win reelection. But the riots, Democrats’ far left turn and possible future revelations about the Russian hoax, may provide enough momentum to put Trump over the top.

July 22, 2020

'Redskins' Is Gone, But Changing 'Washington' Would Be a Much Bigger Job

Given the hundreds of cities, towns, counties, schools, businesses, buildings and bridges that seek to honor the founders’ good deeds, it’s very unlikely the cancel-history crowd will succeed in eliminating their memory.

July 11, 2020

How Trump Can Get His Mojo Back

In this op/ed written for The Hill, the author offers some key points that could impact the election. 

June 23, 2020

Liberal Supreme Court Justices Never Wear the 'Swing Vote' Mantle

When Senate Democrats grill a Republican Supreme Court nominee, they scathingly predict the nominee will be closed minded and vote along ideological lines. The truth is that only liberal justices do that.

June 17, 2020

Did the Trump Tax Cuts 'Work'?

As the November election draws nearer, a key issue will be “Did the Trump tax cuts work?” The answer is an unequivocal “yes.”

June 6, 2020

Liberals: Which 'Science' Are We Supposed to Believe?

What some want to call science is increasingly politics masquerading as science. And nothing has demonstrated that better than the coronavirus. 

June 1, 2020

Attempts to Degrade Drug Patents are Counterproductive in This Pandemic

Compulsory licensing deters innovators from investing in drug discovery. It won’t reduce what patients pay.

May 30, 2020

Bring American Medical Manufacturing Back Home

Important legislation has been proposed that would encourage medical and pharmaceutical manufacturing to relocate to the U.S. by providing potent tax incentives instead of threats of government force.

Total Records: 749